| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.99 | $1.26 | $1.76 | $2.33 | $2.75 | $0.66 | $0.47 | $0.45 |
| EPS (Diluted) | $1.96 | $1.24 | $1.75 | $2.31 | $2.73 | $0.66 | $0.47 | $0.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.0B | $7.1B | $7.2B | $7.0B | $7.4B | $6.6B | $5.6B | $5.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.2B | $0.1B | $1.7B | $0.7B | $0.2B | $0.2B |
| Total Liabilities | $6.0B | $6.2B | $6.3B | $6.2B | $6.6B | $5.8B | $4.7B | $4.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.9B | $0.9B | $0.8B | $0.9B | $0.8B | $0.8B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $0.2B | $-0.1B | $-0.1B | $-1.2B | $0.2B | $-0.5B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.1B | $0.1B | $-0.5B | $0.7B | $1.0B | $0.1B | $0.1B |